Clinical Trial Update: Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing six-day intravenous to oral tedizolid phosphate with a ten-day intravenous to oral linezolid regimen in acute bacterial skin and skin st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• Sivextro (tedizolid)
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Bayer | Conditions: Bacterial Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-06-07